CD79A and immune system disorder: A lack of CCR6 or its ligands, MIP-3α or hBD2, is associated with immune dysfunction including reduced levels of intestinal B cells and regulatory T cells, diminished production of antigen specific IgA, and defects in T cell priming [4,5,6,7,8].